LetterLetter
Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus
ANAND KUMTHEKAR, ABHIJEET DANVE and ATUL DEODHAR
The Journal of Rheumatology September 2017, 44 (9) 1416-1417; DOI: https://doi.org/10.3899/jrheum.170327
ANAND KUMTHEKAR
Fellow in Training, Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University (OHSU), Portland, Oregon;
MDABHIJEET DANVE
Assistant Clinical Professor of Medicine, Division of Rheumatology, Yale University, New Haven, Connecticut;
MDATUL DEODHAR
Professor of Medicine, Division of Arthritis and Rheumatic Diseases, OHSU, Portland, Oregon,
USA.
MDREFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Wallace DJ 1,
- Navarra S,
- Petri MA,
- Gallacher A,
- Thomas M,
- Furie R,
- Levy RA,
- et al;
- BLISS-52 and -76, and LBSL02 Study Groups
- 5.↵
- Manzi S,
- Sánchez-Guerrero J,
- Merrill JT,
- Furie R,
- Gladman D,
- Navarra SV,
- et al;
- BLISS-52 and BLISS-76 Study Groups
- 6.↵
- Yamada M,
- Akita M,
- Nakagawa T,
- Takahashi N,
- Endo A,
- Yoshida P
- 7.↵
- 8.↵
- Bassiri A
- 9.↵Cumulative pregnancy outcomes for belimumab from clinical trials, spontaneous reports, post-marketing surveillance reports, and the Belimumab Pregnancy Registry (BPR). Glakso Smith Kline (GSK) group of companies. March 2016. Data on file.
In this issue
The Journal of Rheumatology
Vol. 44, Issue 9
1 Sep 2017
Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus
ANAND KUMTHEKAR, ABHIJEET DANVE, ATUL DEODHAR
The Journal of Rheumatology Sep 2017, 44 (9) 1416-1417; DOI: 10.3899/jrheum.170327